We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Microscopy Technique Comes Closer to Use in Clinical Diagnostics

By LabMedica International staff writers
Posted on 14 Mar 2023

Diagnostic imaging plays a crucial role in aiding physicians and researchers in understanding internal body structures, thus improving clinical analysis and medical intervention. More...

Scientists continually explore new avenues to utilize imaging technologies to gain insight into human health. A pioneering imaging method called Brillouin microscopy enables the mapping of cell and tissue stiffness, often linked to early symptoms of ailments such as cancer and Alzheimer's. This method is distinct from conventional imaging modalities such as confocal fluorescence microscopy, as it allows label-free and non-contact acquisition of key mechanical information like viscosity and stiffness of biological specimens. Now, researchers are striving to refine Brillouin microscopy, which can answer many important questions in biophysics and mechanobiology.

Brillouin microscopy, an optical imaging method rooted in Brillouin light scattering (BLS), was first introduced by French physicist Léon Brillouin in 1922. When light interacts with a substance, thermal fluctuations or molecular vibrations within the material cause the light to scatter resulting in BLS. These vibrations can be influenced by various factors such as compression, water content, heat, or material stiffness. Among these factors, stiffness is incredibly valuable for the diagnostic application of Brillouin microscopy. Changes in cell stiffness, often linked to the progression of ailments like cancer metastasis, are challenging to measure since cells are microscopic and situated in very delicate tissues.

In conventional approaches, prepared cells are measured on a petri dish or other rigid substrates. However, Brillouin microscopy relies solely on a laser beam to investigate the mechanical properties, enabling measurement when cells are in their physiological conditions. As no physical interaction is required, Brillouin technology is less invasive and more convenient. The technology is important for understanding embryonic tissue development, particularly to gain a better understanding of birth-related diseases and disorders.

Researchers at Wayne State University (Detroit, MI, USA) examined the use of dual line-scanning Brillouin microscopy (dLSBM) to overcome two significant limitations - acquisition speed and irradiation doses - that hinder its widespread usage in biomedicine. The application of dLSBM yielded 50 to 100 times faster speeds than its counterpart, with a reduction of 80 times light irradiation levels for 2D and 3D mechanical mapping.

“With this innovation, we can acquire one mechanical image of cell clusters in a few minutes,” said Jitao Zhang, assistant professor of biomedical engineering (BME) at Wayne State University. “This improved acquisition speed is important because it allows us to investigate details of cell behaviors in almost real time.”

“Due to the 3D structure of an embryo, traditional contact-based techniques encounter big challenges for in vivo measurement,” added Zhang. “Since Brillouin microscopy works in a non-contact manner, it sometimes becomes the only available choice.”

Related Links:
Wayne State University


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Giardia Assay
AccuDiag Giardia
New
Toxoplasma Gondii Test
Toxo IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.